tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Buy Rating for BiomX Amid Temporary Clinical Hold and Strong Financial Position
PremiumRatingsOptimistic Buy Rating for BiomX Amid Temporary Clinical Hold and Strong Financial Position
2M ago
BiomX Faces FDA Hold on Phase 2b Study
Premium
Company Announcements
BiomX Faces FDA Hold on Phase 2b Study
2M ago
BiomX announces U.S. FDA placed clinical hold on Phase 2b trial of BX004
Premium
The Fly
BiomX announces U.S. FDA placed clinical hold on Phase 2b trial of BX004
2M ago
BiomX Sets 2025 Annual Meeting Date
PremiumCompany AnnouncementsBiomX Sets 2025 Annual Meeting Date
3M ago
Promising Clinical Developments and Strategic FDA Discussions Drive Buy Rating for BiomX
Premium
Ratings
Promising Clinical Developments and Strategic FDA Discussions Drive Buy Rating for BiomX
3M ago
BiomX announces successful initiation of Phase 2b trial
Premium
The Fly
BiomX announces successful initiation of Phase 2b trial
4M ago
BiomX price target lowered to $15 from $21 at H.C. Wainwright
PremiumThe FlyBiomX price target lowered to $15 from $21 at H.C. Wainwright
5M ago
BiomX Inc. Reports Q1 2025 Progress and Financials
Premium
Company Announcements
BiomX Inc. Reports Q1 2025 Progress and Financials
5M ago
PHGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PHGE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100